ArticleJAMA network open2019

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.

Alma B Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.